Tivic Health Systems Inc (TIVC) News

Tivic Health Validates European Patents in Great Britain, Germany, and France

Patents cover methods used to identify key treatment points and dynamically personalize simulation Tivic Health® Systems, Inc. (Nasdaq: TIVC), a...

Tivic Health Systems, Inc. to Report Third Quarter 2024 Financial Results on November 14

– Conference Call and Webcast to Follow at 1:30 p.m. PST/4:30 p.m. EST - Tivic Health® Systems, Inc. (Nasdaq: TIVC), a health tech company that...

First Subject Enrolled in Tivic Health’s Optimization Study for its Non-Invasive Vagus Nerve Stimulation Device

Tivic Health® Systems, Inc. (Nasdaq: TIVC), a health tech company developing and commercializing bioelectronic medicine, announced today that the...

Tivic Health CEO Jennifer Ernst to Present at New York BioFuture 2024

- Presentation will highlight Tivic Health’s recent advancements in vagus nerve stimulation - Tivic Health® Systems, Inc. (Nasdaq: TIVC), a...

Form 1-A/A - Offering Statement [Regulation A]: [Amend]

Form 4 - Statement of changes in beneficial ownership of securities

Form 3 - Initial statement of beneficial ownership of securities

Form 8-K - Current report

Tivic Health Receives Approval from Institutional Review Board for ncVNS Optimization Study, Readies for Enrollment

Tivic Health® Systems, Inc. (“Tivic Health”, Nasdaq: TIVC), a health tech company that develops and commercializes bioelectronic medicine, today...

Form 8-K - Current report

Tivic Health Accelerates VNS Commercial Strategy Development

Partners with leading growth strategy firm, Fletcher Spaght Tivic Health® Systems, Inc. (“Tivic Health”, Nasdaq: TIVC), a health tech company...

Tivic Health Appoints Lisa Wolf as Interim Chief Financial Officer

Kimberly Bambach, Ms. Wolf’s predecessor, continues with Tivic as advisor focused on strategic transactions and special projects Tivic Health®...

Form 8-K - Current report

Form 424B5 - Prospectus [Rule 424(b)(5)]

Form 1-A - Offering Statement [Regulation A]